Journal article
Adherence to a Mediterranean diet and Alzheimer's disease risk in an Australian population.
S Gardener, Y Gu, SR Rainey-Smith, JB Keogh, PM Clifton, SL Mathieson, K Taddei, A Mondal, VK Ward, N Scarmeas, M Barnes, KA Ellis, R Head, CL Masters, D Ames, SL Macaulay, CC Rowe, C Szoeke, RN Martins, undefined AIBL Research Group
Translational Psychiatry | Published : 2012
DOI: 10.1038/tp.2012.91
Abstract
The Mediterranean diet (MeDi), due to its correlation with a low morbidity and mortality for many chronic diseases, has been widely recognised as a healthy eating model. We aimed to investigate, in a cross-sectional study, the association between adherence to a MeDi and risk for Alzheimer's disease (AD) and mild cognitive impairment (MCI) in a large, elderly, Australian cohort. Subjects in the Australian Imaging, Biomarkers and Lifestyle Study of Ageing cohort (723 healthy controls (HC), 98 MCI and 149 AD participants) completed the Cancer Council of Victoria Food Frequency Questionnaire. Adherence to the MeDi (0- to 9-point scale with higher scores indicating higher adherence) was the main ..
View full abstractGrants
Awarded by National Institute on Aging
Funding Acknowledgements
Samantha Gardener is supported by a University Postgraduate Award from the Dementia Collaborative Research Centres programme. Nikolaos Scarmeas is supported by a grant from the National Institute on Ageing, RO1 AG028506. Funding for the AIBL study is provided by the CSIRO Flagship Collaboration Fund and the Science and Industry Endowment Fund in partnership with Edith Cowan University, Mental Health Research Institute, Alzheimer's Australia, National Ageing Research Institute, Austin Health, CogState, Hollywood Private Hospital, Sir Charles Gardner Hospital. The study also receives funding from the National Health and Medical Research Council, the Dementia Collaborative Research Centres program, The McCusker Alzheimer's Research Foundation and Operational Infrastructure Support from the Government of Victoria. The AIBL team thank the participants in the AIBL study for their commitment and dedication to helping advance research into the early detection and causation of AD and the clinicians who referred patients to the study.